Gunze Limited – Trademark Portfolio
Entity Type: 03
Gunze Limited owns a portfolio of 59 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as GUNZE, GEOPLAS, G-CELLPY, SANAVEIL, and TENALEAF. Of these, 9 are registered and 5 are pending. The portfolio spans 10 Nice Classification classes, led by Class 25 (Clothing) and Class 10 (Medical Apparatus). Headquartered in Ayabe-shi, Kyoto.
No. 1, Zeze, Aono-cho
Ayabe-shi, Kyoto , JP
Showing of trademarks Trademarks
Trademark Classifications
Gunze Limited's trademark portfolio spans 10 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Gunze Limited have?
Gunze Limited has 59 U.S. trademarks filed with the USPTO. Of these, 9 registered, 5 pending, 15 abandoned, 16 cancelled.
What trademark classes does Gunze Limited file in?
Gunze Limited files trademarks across 10 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus), Class 17 (Rubber Goods), Class 16 (Paper Goods), Class 23 (Yarns & Threads). Class 25 covers clothing, footwear, headgear.
What are Gunze Limited's most well-known trademarks?
Gunze Limited's registered trademark portfolio includes well-known marks such as GUNZE, GEOPLAS, G-CELLPY, SANAVEIL, and TENALEAF. These are among 9 currently registered trademarks in the portfolio.
What is Gunze Limited's trademark registration success rate?
Gunze Limited has a 23% trademark registration rate, with 9 out of 40 resolved applications resulting in successful registration. Currently, 5 applications are pending review.